Back to Search Start Over

Blocking c-Jun-N-terminal kinase signaling can prevent hearing loss induced by both electrode insertion trauma and neomycin ototoxicity

Authors :
Jing Wang
Jean-Luc Puel
Azel Zine
Eelam Adil
Thomas R. Van De Water
Jiao He
Christophe Bonny
Thomas J. Balkany
Adrien A. Eshraghi
Michael Bublik
Hamel, Christian
Cochlear Implant Research Program, Department of Otolaryngology
University of Miami Leonard M. Miller School of Medicine (UMMSM)
Physiopathologie et thérapie des déficits sensoriels et moteurs
Université Montpellier 2 - Sciences et Techniques (UM2)-IFR76-Institut National de la Santé et de la Recherche Médicale (INSERM)
Université de Lausanne = University of Lausanne (UNIL)
Source :
Hearing Research, Hearing Research, Elsevier, 2007, 226 (1-2), pp.168-77. ⟨10.1016/j.heares.2006.09.008⟩
Publication Year :
2007
Publisher :
Elsevier BV, 2007.

Abstract

International audience; Neomycin ototoxicity and electrode insertion trauma both involve activation of the mitogen activated protein kinase (MAPK)/c-Jun-N-terminal kinase (JNK) cell death signal cascade. This article discusses mechanisms of cell death on a cell biology level (e.g. necrosis and apoptosis) and proposes the blocking of JNK signaling as a therapeutic approach for preventing the development of a permanent hearing loss that can be initiated by either neomycin ototoxicity or electrode insertion trauma. Blocking of JNK molecules incorporates the use of a peptide inhibitor (i.e. D-JNKI-1), which is specific for all three isoforms of JNK and has been demonstrated to prevent loss of hearing following either electrode insertion trauma or loss of both hearing and hair cells following exposure to an ototoxic level of neomycin. We present previously unpublished results that control for the effect of perfusate washout of aminoglycoside antibiotic by perfusion of the scala tympani with an inactive form of D-JNKI-1 peptide, i.e. JNKI-1(mut) peptide, which was not presented in the original J. Neurosci. article that tested locally delivered D-JNKI-1 peptide against both noise- and neomycin-induced hearing loss (i.e. Wang, J., Van De Water, T.R., Bonny, C., de Ribaupierre, F., Puel, J.L., Zine, A. 2003a. A peptide inhibitor of c-Jun N-terminal kinase protects against both aminoglycoside and acoustic trauma-induced auditory hair cell death and hearing loss. J. Neurosci. 23, 8596-8607). D-JNKI-1 is a cell permeable peptide that blocks JNK signaling at the level of the three JNK molecular isoforms, which when blocked prevents the increases in hearing thresholds and the loss of auditory hair cells. This unique therapeutic approach may have clinical application for preventing: (1) hearing loss caused by neomycin ototoxicity; and (2) the progressive component of electrode insertion trauma-induced hearing loss.

Details

ISSN :
03785955
Volume :
226
Database :
OpenAIRE
Journal :
Hearing Research
Accession number :
edsair.doi.dedup.....7548a94f786bd4a585c40bd4c1a7c7a5
Full Text :
https://doi.org/10.1016/j.heares.2006.09.008